Medical Xpress news

Medical Xpress / Teclistamab extends remission in relapsed myeloma, with 70% progression-free at 18 months

Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to results from a major ...

6 hours ago
Medical Xpress / Celiac disease may raise risk of heart attack, stroke and early death

People with celiac disease and dermatitis herpetiformis have a slightly increased risk of cardiovascular disease, certain types of blood cancer, and premature death. This is shown by a large U.S. registry study led by researchers ...

9 hours ago
Medical Xpress / Social media bans for teenagers lack evidence and pose risks, scientists say

Bans on teenagers' social media use are gathering pace worldwide. Their proponents claim that social media bans will improve young people's mental health, but what evidence supports these claims? In their new Frontiers in ...

10 hours ago
Medical Xpress / How lifestyle can protect childhood cancer survivors

Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors. These are the findings of two new international studies.

10 hours ago
Medical Xpress / Simulation-guided search uncovers two promising tuberculosis drug candidates targeting CYP

A research team led by Associate Professor Noriyuki Kurita from the Department of Computer Science and Engineering at Toyohashi University of Technology and by Associate Professor Pornpan Pungpo from Ubon Ratchathani University ...

12 hours ago
Medical Xpress / Why metformin matters beyond diabetes: New target could reshape aging and cancer research

Scientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually ...

14 hours ago
Medical Xpress / Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations ...

14 hours ago
Medical Xpress / Unprecedented view inside live stem cells reveals aging process and loss of regenerative capacity

Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins during aging, offering an unprecedented glimpse into the hidden molecular activity of stem cells in ...

May 28, 2026
Medical Xpress / Titanium particles may explain why antibiotics fail against dental implant infections

Dental implants have given tens of millions of people something dentures never could: a full set of fixed and fully functioning teeth. Unfortunately, 10% to 20% of implant patients eventually experience an aggressive jawbone ...

May 28, 2026
Medical Xpress / Lab-grown brain-spinal cord model shows 'irreversible' nerve damage may be reversed

Cambridge scientists have grown miniature circuits in the lab that mimic how the brain and spinal cord connect, which underlies human movement. They used this model to show how damage to these connections previously considered ...

May 28, 2026
Medical Xpress / Blood biomarkers reveal subtle midlife cognitive decline tied to Alzheimer's risk

For the first time, researchers found blood biomarkers for Alzheimer's disease that correlated with minor cognitive differences in midlife adults who did not have dementia. The study, led by UC San Francisco, also found that ...

May 28, 2026
Medical Xpress / New brain scan detects Alzheimer's tau earlier than current standard

A new brain imaging test can detect a key hallmark of Alzheimer's disease before symptoms appear and earlier than the method currently used in clinical practice in the United States and Europe, report University of Pittsburgh ...

May 28, 2026